scholarly journals Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer

2019 ◽  
pp. 20180929 ◽  
Author(s):  
Inyoung Youn ◽  
SeonHyeong Choi ◽  
Yoon Jung Choi ◽  
Ju Hee Moon ◽  
Hee Jin Park ◽  
...  
2021 ◽  
pp. e521
Author(s):  
Anna Grażyńska ◽  
Sofija Antoniuk ◽  
Katarzyna Steinhof-Radwańska

Accurate morphological assessment and measurement of the residual disease following neoadjuvant chemotherapy are vital for the effective surgical treatment in patients with breast cancer. Neoadjuvant chemotherapy response is measured by RECIST 1.1 criteria (Response Evaluation Criteria in Solid Tumors), and the classification of the specific therapeutic responses is based on the difference in the tumour size prior to and after chemotherapy. There are currently a few methods of imaging used in the assessment of the neoadjuvant chemotherapy response. Conventional mammography remains the most popular method, whereas magnetic resonance imaging is considered the most effective ones. Nonetheless, the available methods tend to be imperfect and limited, and therefore, new methods are constantly investigated. Contrast-enhanced spectral mammography is a relatively new method used in breast cancer diagnosis, which involves the phenomenon of neoangiogenesis of cancerous tumours, allowing contrast enhancement in the areas of vessel proliferation in the background of the surrounding breast tissue. Contrast-enhanced spectral mammography presents sensitivity similar to magnetic resonance imaging in breast cancer detection, and can be an efficient method used in monitoring neoadjuvant chemotherapy response.


Surgery Today ◽  
2005 ◽  
Vol 35 (9) ◽  
pp. 720-724 ◽  
Author(s):  
Shuhei Komatsu ◽  
Chol Joo Lee ◽  
Daisuke Ichikawa ◽  
Takashi Hamashima ◽  
Noriaki Morofuji ◽  
...  

2001 ◽  
Vol 8 (5) ◽  
pp. 399-406 ◽  
Author(s):  
Christopher P. Goscin ◽  
Claudia G. Berman ◽  
Robert A. Clark

Background Magnetic resonance imaging (MRI) has the potential to become a useful adjunct in breast imaging. Contrast-enhanced breast MRI has demonstrated a high sensitivity in the detection of invasive breast cancer. In clinical studies, breast MRI has often altered the course of patient care. Although promising results have been generated, MRI of the breast is currently in a development stage. Methods The authors reviewed the literature on the potential indications, sensitivity, specificity, and limitations of MRI of the breast. Results Reported advantages of MRI of the breast over conventional imaging techniques include improved staging and treatment planning, enhanced evaluation of the augmented breast, better detection of recurrence, and improved screening of high-risk women. Contrast-enhanced breast MRI is a sensitive modality for detecting breast cancer, but its variable specificity is a major limitation. Conclusions MRI of the breast is emerging as a valuable adjunct to mammography and sonography for specific clinical indications. Additional clinical studies that define indications, interpretation criteria, imaging parameters, and cost effectiveness are needed. A multi-institutional study designed to address these issues is in progress.


Sign in / Sign up

Export Citation Format

Share Document